Enfeira 100 mg Injection
83.58$
65.20$
Enfeira 100 mg injection is a targeted monoclonal antibody therapy designed to effectively address various immune-related conditions, particularly certain hematological malignancies. This medication plays a pivotal role in the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia, working by specifically binding to cancer cells and marking them for destruction by the immune system. Patients considering Enfeira should be aware of potential side effects, including infusion reactions and increased risk of infections, necessitating close monitoring by healthcare professionals. It is crucial for individuals to discuss their medical history and any other medications they are taking before initiating treatment with Enfeira. By enhancing the body’s natural immune response, this innovative injection offers hope for those battling these challenging cancers. Furthermore, proper administration and adherence to dosing schedules can significantly impact treatment efficacy. With its targeted action and ongoing clinical support, Enfeira continues to be an important option in modern oncology. Always consult with a qualified healthcare provider to determine if Enfeira is the right choice for your treatment plan.
الكمية
Active Pharmaceutical Ingredient
Uses
• Enfeira 100 mg injection is primarily used to treat non-Hodgkin lymphoma (NHL), a type of blood cancer that affects the lymphatic system. This medication helps to manage the symptoms associated with NHL by targeting the cancerous cells. Patients receiving Enfeira 100 mg injection may experience improved outcomes in their treatment plan. It is often utilized in conjunction with other therapies to enhance its effectiveness.
• In cases of rheumatoid arthritis, Enfeira 100 mg injection provides relief by reducing inflammation and slowing disease progression. This medication helps to alleviate joint pain and stiffness, allowing patients to maintain better mobility. By incorporating Enfeira 100 mg injection into their treatment regimen, individuals can experience significant improvements in their quality of life. It is particularly beneficial for those who have not responded adequately to other treatments.
• Enfeira 100 mg injection is also indicated for the treatment of chronic lymphocytic leukaemia (CLL), another form of blood cancer. This medication works by inhibiting the growth of cancer cells, which can help to stabilize the disease. Patients may receive Enfeira 100 mg injection as part of a comprehensive treatment approach, often alongside other therapies. Its role in managing CLL contributes to improved patient outcomes and symptom control.
• Additionally, Enfeira 100 mg injection is effective in treating conditions such as granulomatosis with polyangiitis and microscopic polyangiitis. These disorders involve inflammation of blood vessels, and Enfeira 100 mg injection helps to reduce this inflammation. By doing so, it can prevent complications and promote recovery in affected individuals. The use of Enfeira 100 mg injection in these scenarios highlights its versatility in managing autoimmune and hematologic disorders.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Enfeira 100 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician.
Rheumatoid arthritis: Enfeira 100 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician.
Blood cancer (chronic lymphocytic leukemia): Leukemia, also known as blood cancer, is a malignant neoplasm of the hematopoietic tissues that impairs the body's ability to combat infection. Enfeira 100 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment.
Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Enfeira 100 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA.
Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Enfeira 100 mg Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Enfeira 100 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Enfeira 100 Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Enfeira 100 mg. Please consult your doctor.
• Kidney: Enfeira 100 mg Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Enfeira 100 mg Injection is likely to be safe to use while breastfeeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Enfeira 100 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Enfeira 100 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Enfeira 100 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.